Indian pharma stocks 'breathe easy' on US tariffs exemption
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 03 2025
0mins
Source: Reuters
Pharmaceutical Sector Surge: Indian drugmakers' shares rose 5% following the U.S. exemption of pharmaceuticals from new tariffs, contrasting with a broader market decline. The pharma index is set for its best intra-day performance in over four years.
Impact on Exports and Future Risks: The exemption is crucial for India's pharma sector, which exports nearly a third of its products to the U.S., but analysts warn that future tariffs specific to pharmaceuticals cannot be entirely ruled out.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
